241 related articles for article (PubMed ID: 26496314)
1. Statin-Based Palliative Therapy for Hepatocellular Carcinoma.
Shao JY; Lee FP; Chang CL; Wu SY
Medicine (Baltimore); 2015 Oct; 94(42):e1801. PubMed ID: 26496314
[TBL] [Abstract][Full Text] [Related]
2. Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients.
Wu LL; Hsieh MC; Chow JM; Liu SH; Chang CL; Wu SY
Medicine (Baltimore); 2016 Sep; 95(36):e4639. PubMed ID: 27603355
[TBL] [Abstract][Full Text] [Related]
3. Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma.
Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
Eur J Clin Invest; 2023 Apr; 53(4):e13936. PubMed ID: 36504405
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
[TBL] [Abstract][Full Text] [Related]
5. Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Goh MJ; Sinn DH; Kim S; Woo SY; Cho H; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Hepatology; 2020 Jun; 71(6):2023-2032. PubMed ID: 31556128
[TBL] [Abstract][Full Text] [Related]
6. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
[TBL] [Abstract][Full Text] [Related]
7. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis.
Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L
BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib use in hepatitis B virus- or hepatitis C virus-related hepatocellular carcinoma: A propensity score matching study.
Lee YC; Wang JH; Chen CH; Hung CH; Lo KC; Yen YH; Kee KM; Hu TH; Lu SN; Kuo YH
Kaohsiung J Med Sci; 2021 Oct; 37(10):894-902. PubMed ID: 34166565
[TBL] [Abstract][Full Text] [Related]
9. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
Tsan YT; Lee CH; Wang JD; Chen PC
J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
[TBL] [Abstract][Full Text] [Related]
10. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
Chang FM; Wang YP; Lang HC; Tsai CF; Hou MC; Lee FY; Lu CL
Hepatology; 2017 Sep; 66(3):896-907. PubMed ID: 28318053
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
12. Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience.
Chen VL; Yeh ML; Le AK; Jun M; Saeed WK; Yang JD; Huang CF; Lee HY; Tsai PC; Lee MH; Giama N; Kim NG; Nguyen PP; Dang H; Ali HA; Zhang N; Huang JF; Dai CY; Chuang WL; Roberts LR; Jun DW; Lim YS; Yu ML; Nguyen MH
Aliment Pharmacol Ther; 2018 Jul; 48(1):44-54. PubMed ID: 29797518
[TBL] [Abstract][Full Text] [Related]
13. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus-related hepatocellular carcinoma presenting at an advanced stage: is it preventable?
Mules T; Gane E; Lithgow O; Bartlett A; McCall J
N Z Med J; 2018 Nov; 131(1486):27-35. PubMed ID: 30496164
[TBL] [Abstract][Full Text] [Related]
15. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality.
Thrift AP; Natarajan Y; Liu Y; El-Serag HB
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2117-2125.e3. PubMed ID: 30625400
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of adjuvant pegylated interferon therapy for metastatic tumor antigen 1-positive hepatocellular carcinoma.
Lee D; Chung YH; Kim JA; Park WH; Jin YJ; Shim JH; Ryu SH; Jang MK; Yu E; Lee YJ
Cancer; 2013 Jun; 119(12):2239-46. PubMed ID: 23564564
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: high hepatitis B viral load and mortality in patients treated with transarterial chemoembolization.
Yu SJ; Lee JH; Jang ES; Cho EJ; Kwak MS; Yoon JH; Lee HS; Kim CY; Kim YJ
Radiology; 2013 May; 267(2):638-47. PubMed ID: 23440326
[TBL] [Abstract][Full Text] [Related]
18. Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States.
Davila JA; Duan Z; McGlynn KA; El-Serag HB
J Clin Gastroenterol; 2012 Jan; 46(1):71-7. PubMed ID: 22157221
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
Makarova M; Krettek A; Valkov MY; Grjibovski AM
Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
[TBL] [Abstract][Full Text] [Related]
20. Cancer risk in HBV patients with statin and metformin use: a population-based cohort study.
Chen CI; Kuan CF; Fang YA; Liu SH; Liu JC; Wu LL; Chang CJ; Yang HC; Hwang J; Miser JS; Wu SY
Medicine (Baltimore); 2015 Feb; 94(6):e462. PubMed ID: 25674734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
